FOR INDIANA’S FRONTLINE RESPONDERS
The COVID-19 Daily Digest is made possible by WISE Indiana (Wellbeing Informed by Science and Evidence in Indiana) – a partnership between the Indiana Clinical and Translational Sciences Institute’s Monon Collaborative and the Indiana Family and Social Services Administration to engage Indiana’s nationally-recognized academic experts to evaluate and inform Indiana practices, programs and policies.
| Indiana | |
| Confirmed Cases | Deaths |
| 1,077,372 | 16,737 |
| Updated 11-21-2021 @ 11:59 pm |
|
| USA | |
| Confirmed Cases | Deaths |
| 48,754,985 | 794,965 |
| Updated 11-23-2021 @ 11:33 am |
|
| World | |
| Confirmed Cases | Deaths |
| 258,457,605 | 5,163,506 |
| Updated 11-23-2021 @ 10:22 am |
|
At the end of 2021, WISE Indiana will no longer be updating the COVID-19 Daily Digest. Thank you to all of the contributors and readers. We hope that you have found the Daily Digest as a valuable resource throughout the pandemic. We look forward to providing you with more WISE Indiana specific updates in the coming year.
EXPERT REVIEWS OF RELEVANT AND EMERGING LITERATURE
Monthly Review: COVID-19 Data and Surveillance – November 22, 2021
Monthly Review: Communicating COVID-19 – November 15, 2021
With the recent approval of COVID-19 vaccines for nearly all age groups and many organizations
Read MoreMonthly Review: COVID-19 Health Equity – November 1, 2021
Women’s Health and COVID-19
Indeed, the COVID-19 pandemic disrupted health care delivery as we know
Read MoreMonthly Review: COVID-19 Data and Surveillance – October 25, 2021
Breakthrough Infections
This preprint retrospective analysis identifies risk factors associated with breakthrough
Read MoreSTATE UPDATES
COVID-19 Vaccination in Indiana (IDOH)
Anyone age 5 and older may now schedule a COVID-19 vaccination appointment. Click here to register or call 211 (866-211-9966) if you do not have access to a computer or need assistance. Walk-in appointments are also accepted at most vaccination sites, but registration is encouraged to ensure the appropriate dose is available at your chosen location.
IHIE Indiana COVID-19 Vaccination Data Report (IHIE)
The intent of these documents is to provide weekly updates on county-specific vaccination rates, particularly as they compare to hesitant or vulnerable populations, to help identify where vaccination outreach opportunities and planning efforts should be focused.
Indiana COVID-19 Vaccination Dashboard (IDOH)
IDOH’s Vaccination Dashboard provides updates on Indiana’s progress to vaccinate Hoosiers against COVID-19. Data is updated at 12:00 PM EST.
NATIONAL/INTERNATIONAL UPDATES
FDA Expands Eligibility for COVID-19 Vaccine Boosters (FDA)
On November 19, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine. The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices will meet later today to discuss further clinical recommendations.
World Health Organization Weekly Epidemiological Update (WHO)
During the week 8 to 14 November 2021, the increasing trend in new global weekly cases continued, with over 3.3 million new cases reported – a 6% increase as compared to the previous week. The Region of the Americas, the European and the Western Pacific Regions all reported increases in new weekly cases as compared to the previous week, while the other regions reported stable or declining trends. Similarly, the European Region reported a 5% increase in new deaths, while the other regions reported stable or declining trends. Globally, just under 50,000 new deaths were reported, similar to the previous week’s figures. As of 14 November, over 252 million confirmed cases and over 5 million deaths have been reported.
EXPERT RESPONSES TO KEY QUESTIONS
These documents were prepared by teams of research librarians and faculty experts in response to specific questions posed by individuals involved in Indiana’s frontline COVID-19 response. They summarize information that frontline responders may find useful. Please note that information is current for the dates specified. New studies, priorities and literature are being published daily, and best practices are rapidly evolving. These documents do not represent clinical guidelines, standard operating procedures, or the opinions or positions of FSSA.
- Pfizer Summary of Vaccine Characteristics and Progress
- Moderna Summary of Vaccine Characteristics and Progress
- Johnson & Johnson Summary of Vaccine Characteristics and Progress
- Adverse Events of Varying COVID-19 Vaccines
- What is the national incidence of MIS-C requiring hospitalizations among various pediatric age groups? How long are these children hospitalized and what are their overall outcomes?
- What is the national incidence of long COVID among various pediatric age groups? What do we know about the duration of symptoms and return to regular activities including school?